A randomized, open label trial to evaluate and compare the immunogenicity and safety of a novel liquid hexavalent DTwP-Hib/Hep B-IPV (EasySix™) to licensed combination vaccines in healthy infants
- 1 April 2018
- Vol. 36 (17) , 2378-2384
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Combined immunogenicity data for a new DTaP-IPV-Hep B-PRP-T vaccine (Hexaxim™) following primary series administration at 2, 4, 6 months of age in Latin AmericaVaccine, 2013
- Immunogenicity and Safety of an Investigational Hexavalent Diphtheria-tetanus-acellular Pertussis-inactivated Poliovirus-hepatitis B-Haemophilus influenzae B Conjugate Combined Vaccine in Healthy 2-, 4-, and 6-month-old Argentinean InfantsThe Pediatric Infectious Disease Journal, 2011
- Combination VaccinesJournal of Global Infectious Diseases, 2011
- Correlates of Protection Induced by VaccinationClinical and Vaccine Immunology, 2010
- Evaluation of the immunogenicity and safety of an indigenously developed DTwP-Hib tetravalent combination vaccine (Shan 4) with EasyFourTM in Indian infants administered per EPI scheduleHuman Vaccines, 2010
- Adverse events following hexavalent vaccine (Hexavac): Knowledge and informative sourcesVaccine, 2005
- Evaluating the Immune Response to Combination VaccinesClinical Infectious Diseases, 2001
- Combined and Simultaneously Administered VaccinesAnnals of the New York Academy of Sciences, 1995
- Characterization of the serum antibody response induced by Haemophilus influenzae type b tetanus protein-conjugate vaccine in infants receiving a DTP-combined vaccine from 2 months of ageVaccine, 1993
- Safety and immunogenicity of Haemophilus type b-tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis vaccine in young infantsThe Pediatric Infectious Disease Journal, 1991